Mesoblast Limited (MESO) NASDAQ
14.55
-0.315(-2.12%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
14.55
-0.315(-2.12%)
Currency In USD
| Market Cap | 1.32B |
| Enterprise Value | 1.28B |
| P/E Ratio | -23.98 |
| PEG Ratio | -7.6 |
| Price/Sales Ratio | 121.83 |
| Price/Book Ratio | 3.26 |
| Enterprise/Revenue | 122.19 |
| Enterprise/EBITDA | -39.17 |
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -5 |
| Operating Margin | -5.72 |
| Return On Assets | -0.1 |
| Return On Equity | -0.14 |
| Revenue | 17.2M |
| Revenue/Share | 0.01 |
| Gross Profit | 12.07M |
| EBITDA | -73.66M |
| Net Income | -102.14M |
| Diluted EPS | -0.84 |
| Total Cash | 129.57M |
| Total Cash/Share | 0.1 |
| Total Debt | 135.14M |
| Total Debt/Equity | 0.24 |
| Current Ratio | 1.58 |
| Book Value Per Share | 0.45 |
| 52-Week Change | 40.13 |
| 52-Week High | 21.5 |
| 52-Week Low | 9.88 |
| Moving Average 50 Days | 15.08 |
| Moving Average 200 Days | 16.31 |
| Average Volume | 238,519 |
| Shares Outstanding | 128.69M |
| % Held by Institutions | 2.58 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
| Last Split Date | January 10, 2024 |